glp-1 receptor agonist brands Five Unexpected New Uses for Agonists Currently available glucagon-like peptide-1 receptor
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 29.Meier JJ, Gallwitz B, Salmen S, Goetze O, Holst JJ, Schmidt WE, Nauck MA

These events are dose-dependent and most pronounced during dose escalation

Gerich, J

Inclusion in the MDL does not establish that Trulicity caused any injury, but it reflects that plaintiffs are raising overlapping allegations across the GLP-1 drug category

Novo Nordisk 2024 Annual Report (Form 6-K) February 2025

Mounjaro introduced tirzepatide as a dual GIP/GLP-1 receptor agonist for type 2 diabetes
